MatrixOI® Fusion Matters
Providing the next generation
of regenerative therapies.
Call us today at
(877) 887-3436
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
MatrixOI®
Matrix OI® is a compressible Stem Cell Containment™ matrix derived from 100% human bone.
Each lot of Matrix OI® is tested for osteoinductivity post sterilization in-vivo for 28 days in an athymic rat to ensure the presence of bone morphogenic proteins. BMP’s promote mesenchymal (BMA) cells to differentiate into chondrocytes and osteoblasts that lead to bone formation. Preserved native BMP’s provide for an unparalleled osteoactive grafting material.
Matrix OI® is processed using CellRight Technologies® next-generation proprietary processing method that maintains the interconnected structure of trabecular bone in a manner that preserves native bone morphogenic proteins. It allows the clinician to hydrate it with the patient’s own stem cells, BMA, growth factors, PRP, or other cellular components in accordance with a physicians well-informed medical judgment.
Matrix OI® is indicated for homologous use in:
- Cervical and lumbar spine
- Scoliosis
- Lateral gutters
- Orthopedics
- Bone voids
- Reconstruction
- CMF
- Non-unions
- Foot and ankle
- Dental procedures
When hydrated, Matrix OI® is a compressible scaffold that will contour with the defect.
Features and Benefits
- Osteoinductive – each lot is in-vivo tested and each lot is assayed
- Osteoconductive
- Sterile – Sterility Assurance Level (SAL) of 10-6
- Five year shelf-life
- 100% bone – no additional carrier
- Ambient storage and shipping temperatures
- Resists migration
- Hydrates in minutes
- Available in custom sizes
Call us today at
(877) 887-3436
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”